Roots Analysis has announced the addition of Cell and Gene Therapy Bioassay Services Market report to its list of offerings.
During our research, we were able to capture more than 40 players, which claims to offer bioassay services related for cell and gene therapies.
Amongst the total players offering bioassay services for cell and gene therapies, most of the players engaged in this domain were established before 1995. Of these, nine are headquartered in North America, while eight are based in Europe. Further, the industry witnessed the establishment of nine players, post 2010. Of these, five are based in North America, three in Europe and one in the Asia-Pacific region. In addition to this, all of the bioassay service providers (100%) are offering pre-developed assay. This is followed by 89% players that offer customized assays for cell and gene therapies.
To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market/request-sample.html
Scope of the Report –
The “Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030” report features an extensive study of the current landscape and the likely future potential of cell and gene therapy bioassay service providers, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the study includes:
- A detailed assessment of the overall market landscape of the cell and gene therapy bioassay services market, providing information on their year of establishment, company size, location of headquarters, location of bioanalytical facilities, type of offering (in vitro and in vivo), type of bioassay(s) offered (pre-developed assay and customized assay), type of bioanalytical services (immunoassay, potency assay, qualitative PCR, digital droplet PCR, flow cytometry, ELISA, immunochemistry and others) and application area (cell therapy, gene therapy and others).
- A detailed competitiveness analysis of the cell and gene therapy bioassay service providers based in different geographies, by taking into consideration their service strength (in terms of bioassay offering(s) and number of bioanalytical services offered), service applicability (in terms of number of bioassays offered and application area) and supplier strength (in terms of years of experience in this field and company size).
- Tabulated profiles of key players offering a wide range of cell and gene therapy bioassay services across North America, Europe and Asia-Pacific. Each profile includes an overview of the company, financial information (if available), details of its cell and gene therapy bioassay services portfolio, types of offerings, type of bioassay(s) offered, types of bioanalytical services offered, application area, location of bioanalytical facilities, recent developments and an informed future outlook.
- An insightful contemporary market trend analysis, featuring the distribution of cell and gene therapy service providers by type of bioanalytical services offered and application area and an analysis of cell and gene therapy service providers, based on type of bioassay and types of bioanalytical services offered. Further, the chapter also features a schematic world map representation, highlighting the location of bioanalytical facilities of cell and gene therapy bioassay service providers.
- A detailed analysis of the global events attended by the service providers, based on year of event, type of event, type of services involved and application area, and strategic initiatives taken by various cell and gene therapy bioassay service providers.
- A case study of the overall landscape of cell and gene therapy therapeutics market, based on a number of parameters. The market landscape of cell therapies, features distribution of cell therapies across phase of development, therapeutic area and type of developer. Further, the market landscape of cell therapies, features distribution of gene therapies across phase of development of pipeline candidates and key therapeutic areas. The chapter also features information on the developers involved in the domain of cell and gene therapies.
- An in-depth analysis of more than 260 cell therapy developers that are anticipated to partner with cell and gene therapy bioassay service providers and have been shortlisted on the basis of several relevant parameters, such as developer strength (which takes into account a company’s size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development) and availability of other cell therapy capabilities.
To request a free insight to this report – https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market/free-insights.html
Majority of the service providers (56%) have established their facilities in North America; within this region, most of the facilities are located in US (97%), followed by Canada (3%). Further, close to 40% players have their manufacturing facilities in Europe, while the remaining have established their facilities in Asia-Pacific and rest of the world (~10%). It is worth highlighting that, in Asia-Pacific, majority of the service providers have established their facilities in China (75%), followed by Singapore (25%).
Further, as can be observed from the figure, majority (66%) of the players offers type 1 assay for both cell as well as gene therapies, followed by type 2 assay which is offered by close to 60% bioassay service providers. Besides this, ~50% service providers offer type 1 assay in in vitro medium, whereas only 30% players provide type 1 assay in in vivo medium. On the other hand, type 2 assay is offered by over 40% of the service providers in in vitro medium and over 25% players provide type 2 assay in in vivo medium. Additionally, the other application area includes vaccines, monoclonal antibodies, viral vectors and immuno-oncology.
To request a customization to this report – https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market/request-customization.html
Key Questions Answered
- Who are the leading services providers offering bioassay services related to cell and gene therapies?
- What is the relative competitiveness of different cell and gene therapy bioassay service providers?
- Which is the commonly offered bioanalytical service (immunoassay, potency assay, qualitative PCR, digital droplet PCR, flow cytometry, ELISA, immunochemistry and others) related to cell and gene therapy?
- What are the key trends within the cell and gene therapy bioassay service providers market?
- What kind of initiatives are being taken by stakeholders engaged in this domain?
- Which players are likely to partner with cell and gene therapy bioassay service providers?
- How is the current and future opportunity likely to be distributed across key market segments?
- What are the anticipated future trends related to teleradiology services market?
For additional details, please visit - https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market.htmlOr sales@rootsanalysis.com
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Details
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
